Cardiogenic Necrotizing Enterocolitis in Infants with Congenital Heart Disease: A Systematic Review and Meta-analysis
Pediatric Cardiology · 2025-12 · 46 (8) · 2429-2442
DOI: 10.1007/s00246-024-03686-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Cardiology, online erschienen am 29.10.2024. Verfasst von Ivor B Asztalos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, 340…. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Heart Defects, Congenital. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Necrotizing enterocolitis (NEC) is a known cause of morbidity and mortality in infants with congenital heart disease (CHD), but reports about the burden of cardiogenic NEC frequently conflict. To synthesize the extant literature on the incidence, risk factors, and prognosis of NEC in patients with CHD. Medline, Cochrane, and EMBASE were searched from 1946 through 2023 for studies of NEC in infants 0–12 months of age with CHD. Risk of bias was assessed with validated tools for incidence and risk factors. Pooled estimates were meta-analyzed by risk of bias or synthesized without meta-analysis. Eighty-six studies with a total of 67,924 participants were included. The incidence of cardiogenic NEC was 7.1% (95% CI 4.7–10.5%) in term infants and 13.0% (10.2–16.5%) in low birthweight preterm infants. NEC required surgery in 0.8% (0.5–1.1%) of term and 2.7% (2.0–3.7%) of premature infants, respectively. Only gestational age and birth weight were consistently associated with risk of NEC. Restricting pooled estimates to studies of moderate or low risk of bias significantly reduced the number of studies included. Necrotizing enterocolitis is a common cause of morbidity in infants with CHD, but additional research is needed to determine which infants are at highest risk of developing NEC and would benefit most from a change in management. This systematic review and meta-analysis was conducted according to a prespecified protocol registered at the Prospective Register of Systematic Reviews (CRD42021282114).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, 3401 Civic Center Blvd, 8NW85, Philadelphia, PA, 19104, USA. asztalosi@ch…
- Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, 3401 Civic Center Blvd, Philadelphia, PA, 19104, USA.
- Division of Cardiology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado Denver, 13123 E 16th Ave, Anschutz Medical Campus, Aurora, CO, 80045-2560, USA.
- Clinical Nutrition, Cardiac Center, Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA, 19104, USA.
Zitieren
APA
Asztalos, I. B., Hill, S. N., Nash, D. B., Schachtner, S. K., & Palm, K. J. (2025). Cardiogenic Necrotizing Enterocolitis in Infants with Congenital Heart Disease: A Systematic Review and Meta-analysis. Pediatric Cardiology, 46(8), 2429-2442. https://doi.org/10.1007/s00246-024-03686-4
Vancouver
Asztalos IB, Hill SN, Nash DB, Schachtner SK, Palm KJ. Cardiogenic Necrotizing Enterocolitis in Infants with Congenital Heart Disease: A Systematic Review and Meta-analysis. Pediatric Cardiology. 2025;46(8):2429-2442. doi:10.1007/s00246-024-03686-4
BibTeX
@article{Asztalos2025,
author = {Asztalos, Ivor B and Hill, Stephanie N and Nash, Dustin B and Schachtner, Susan K and Palm, Kelsey J},
title = {Cardiogenic Necrotizing Enterocolitis in Infants with Congenital Heart Disease: A Systematic Review and Meta-analysis},
journal = {Pediatric Cardiology},
year = {2025},
volume = {46},
number = {8},
pages = {2429--2442},
doi = {10.1007/s00246-024-03686-4}
}
EUVIMED